# Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study

> **NCT06555393** · PHASE1 · RECRUITING · sponsor: **University of Alberta** · enrollment: 28 (estimated)

## Conditions studied

- High Blood Sugar
- High Blood Pressure
- Overweight and Obesity

## Interventions

- **DIETARY_SUPPLEMENT:** Egg White Powder

## Key facts

- **NCT ID:** NCT06555393
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-25
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06555393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06555393, "Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06555393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*